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Objective: To present the case of a 20-year-old collegiate
wrestler who suffered from atypical chest pains and syncope
after rigorous exercise, dehydration, and ingestion of a meta-
bolic stimulant.
Background: As a result of pressure to obtain a lower body
weight for competition, wrestlers often pursue practices to lose
a substantial amount of weight in a short period of time. These
practices include rigorous exercise, starvation, dehydration,
laxatives, diuretics, and over-the-counter stimulants. Our case
involves an athlete who ingested a metabolic stimulant contain-
ing ma huang (ephedrine) and suffered from syncope and
atypical chest pains during a bout of rigorous exercise and
dehydration to lose weight for competition.
Differential Diagnosis: Hypertrophic cardiomyopathy, elec-
trolyte imbalance, drug overdose, traumatic head injury, myo-
cardial infarction, syncope.
For scholastic and collegiate wrestlers, the pressure to
attain and maintain a certain weight class is substantial.
Wrestlers often rely on extended bouts of rigorous
exercise, in combination with starvation and dehydration, to
attain a competitive weight. 1-3 Unfortunately, wrestlers will
often go so far as to pursue practices designed for a substantial
amount of weight loss over a short period of time, including the
use of saunas, hot boxes, steam rooms, impermeable rubber or
nylon suits, laxatives, and diuretics.2'3 As in our patient's case,
wrestlers occasionally use over-the-counter (OTC) metabolic
stimulants, which are available at most nutritional stores.
Nutrition stores market these supplements to increase the
body's metabolism, leading to an increase in weight loss.4
Because these stimulants are marketed as "natural" and are so
readily available, users feel they are safe.58 Even though these
stimulants are believed by the public to be safe, they some-
times contain Chinese herbal extracts, like ma huang extract,
which has known side effects. The purpose of our paper is to
report the case of an intercollegiate wrestler who suffered from
syncope and atypical chest pains during a rigorous bout of
exercise and dehydration after ingestion of an OTC stimulant
containing ephedrine (ma huang) and caffeine.
Treatment: The emergency medical services transported
the athlete to the emergency room, and he was hospitalized for
2 days. After discharge, the team physician counseled the
athlete in the dangers of metabolic stimulants and excessive
weight-loss techniques.
Uniqueness: This case is unique because it presents an
athlete who ingested an over-the-counter stimulant to lose
weight and suffered from syncope and atypical chest pains
during a bout of rigorous exercise and dehydration.
Conclusions: Athletic trainers must understand not only the
dangers of excessive weight loss, but also the dangers of using
unregulated ephedrine-containing stimulants to aid in weight
loss.
Key Words: wrestling, Chinese herbal stimulants, ephedrine,
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REPORT OF THE CASE
A 20-year-old African-American male intercollegiate wres-
tler weighing approximately 61.23 kg experienced severe
substernal chest pain, tachycardia, hyperventilation, and loss of
consciousness during wrestling practice. Before the incident,
the athlete had no previous history of cardiac pain or dysfunc-
tion. The athletic trainer intervened by initiating the prepared
emergency action plan for prompt arrival by the emergency
medical services. Initially, the supine athlete experienced an
altered state of consciousness in which he did not always
respond to verbal cues. He eventually described his chest pain
as "chest pressure"; however, he reported no abnormal sensa-
tions into the upper extremities. Although the athlete was
conscious when the emergency medical services arrived, his
heart rate was significantly elevated (160 beats per minute).
Upon arrival at the emergency room, the athlete had a blood
pressure of 120/80 mm Hg and a pulse of 90 beats per minute.
He was coherent and oriented but continued to suffer from
intermittent chest pain, and his breathing was quick and
shallow for approximately 2 hours. The athlete was admitted to
the hospital for further evaluation.
At the emergency room, the athlete revealed that he had
ingested a metabolic stimulant known as Ripped Fuel (Twin
Lab, Ronkonkoma, NY). Ripped Fuel is available at most
stores specializing in nutritional supplements. The athlete
admitted taking 4 tablets daily for 2 months, 2 tablets at
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breakfast and 2 tablets at dinner. On the day of the incident,
with no food or beverage consumption for that day, the athlete
ingested 2 tablets just before practice. His rationale for taking
the medication was to increase his basal metabolism to aid in
weight loss.
The athlete underwent a battery of tests during his hospital-
ization. An electrocardiogram revealed normal cardiac inter-
vals and normal sinus rhythm. A Holter cardiac monitor of
cardiac activity over a 24-hour period revealed no cardiac
arrhythmia. An echocardiogram revealed no hypertrophic car-
diomyopathy, and an arterial blood gas test ruled out the
possibility of a pulmonary embolus. Urinalysis revealed an
increased level of creatinine in his urine secondary to dehy-
dration (the athlete reported no history of creatine supplement
usage) and the presence of ephedrine. One day after the
incident, the athlete performed a cardiovascular exercise toler-
ance test. He had minor chest pain lasting about 15 seconds
during minute 16 of exercise, with normal cardiac rate, rhythm,
and blood pressure and no signs of ischemia. Because the
athlete lost consciousness and experienced hyperventilation,
tachycardia, increased creatinine level, and atypical chest pain,
the team physician diagnosed the athlete as suffering from
syncope and atypical chest pains resulting from a combination
of dehydration, physical stress, and use of the metabolic
stimulant.
The athlete followed up with the team physician 4 days after
the incident and was counseled about the dangers of nutritional
supplements in combination with excessive weight loss. He
was advised not to take medications containing ephedrine and
pseudoephedrine without consulting a physician and to screen
all medications with the team physician and athletic trainer.
The team physician examined and cleared the athlete 4 days
after the incident. The athlete has had no recurrence of signs
and symptoms and has not used metabolic stimulants.
DISCUSSION
This athlete attempted to lose approximately 4.54 to 6.80 kg
(10 to 15 lb) to compete in the 57.15-kg (126-lb) weight class.
To aid in his weight loss, he ingested Ripped Fuel to theoret-
ically increase his metabolism, thereby decreasing his weight.
Ripped Fuel contains caffeine and a derivative of ephedrine
called ma huang. Ma huang is extracted from the Ephedra
species and has been used in Far Eastern societies for thou-
sands of years.6 In Western society, ma huang is marketed as
a diet or energy pill.4 Because ma huang is considered a
nutritional supplement, it is not subject to the controls and
vigorous testing of the Food and Drug Administration
(FDA).4'8'3 Even though ma huang is not strictly regulated,
the FDA, through the MEDwatch program, is well aware of the
dangers involved with its use. The MEDwatch program asks
health professionals, as well as federal, state, and local health
agencies, to voluntarily report adverse effects resulting from
dietary supplement use.9'14 On April 10, 1996, the FDA issued
a warning to consumers to avoid nutritional supplements
containing ephedrine.'5 In addition, the FDA proposed, and is
currently deliberating over, the use of warning labels address-
ing the adverse effects of ephedrine and the banning of
products containing more than 8 mg per serving and those
containing ephedrine in combination with caffeine (like Ripped
Fuel), as well as limiting product use to 7 days.16-18 No
clinical studies have proved the safety or claimed benefits of
ma huang products.4
Over the past decade, over 500 reported adverse effects,
including more than 15 deaths, have resulted from the use of
ephedrine products like ma huang.171920 Theoharides18 re-
ported the death of a healthy 23-year-old male who regularly
consumed 1 or 2 Ripped Fuel drinks daily over a 6-month
period. The autopsy revealed myocardial necrosis associated
with ephedrine toxicity. The Centers for Disease Control and
Prevention19 reported on a 38-year-old male who suffered from
seizures and syncope after ingestion of an ephedrine-
containing product. A 35-year-old woman used ephedrine to
aid in weight loss,'9 and, although she used the recommended
dose for 30 days, she experienced anterior chest pain and
shortness of breath.19 Wiener et a12' reported crushing chest
pains suffered by a 28-year-old healthy male after ingestion of
an ephedrine alkaloid (pseudoephedrine). A case report by
Derreza et a122 revealed substernal chest pain, shortness of
breath, and diaphoresis after pseudoephedrine ingestion. Cock-
ings and Brown23 reported diffuse myocardial injury in a
25-year-old male after intravenous injection of ephedrine as a
substitute for an illicit street drug. Finally, Weesner et a124
reported a 14-year-old female who suffered from chest pain,
dizziness, tachycardia, and blurred vision after ingestion of an
OTC stimulant containing ephedrine and caffeine. Possible
adverse effects experienced with ma huang use are presented in
the Table. The athlete in this case suffered from substernal
sharp chest pains, syncope, tachycardia, and hyperventilation,
all of which are reported in the literature as possible adverse
effects from ephedrine use. Since the athlete admittedly con-
sumed the Ripped Fuel before practice, it is feasible that his
signs and symptoms resulted from the ephedrine-containing
product.
The goal of excessive weight loss in wrestling is to qualify
at a lower weight class, where the wrestler believes he will be
bigger, stronger, and faster and possess greater leverage over
his opponent.3 Excessive weight loss to make a lower weight
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class may occur 15 to 30 times over a 4-month period.3 As a
result of dehydration, wrestlers often shed as much as 4% to
5% of their body weights on the day of competition.3 Brownell
et all reported that most athletes who participate in sports with
specific weight categories like wrestling compete at levels 5%
to 10% lower than their normal body weights. Being dehy-
drated has many adverse effects on both athletic performance
and overall health. Dehydration decreases muscle strength,
decreases work performance, and lowers blood volume and
liver glycogen, as well as affecting thermoregulation." 3'31-33
Elite wrestlers who lost 8% of their body weight exhibited
decreased speed with uphill sprinting and isometric endur-
ance.33 Both of these deficits are important indicators of
athletic performance. A study of 9 intercollegiate wrestlers
involved testing their peak work capacity before and after
excessive weight loss over a 4-day period and revealed
decreased work capacity.3' The mean weight loss for the
9-wrestler subject pool was 4.8% of body weight. After
rehydration to simulate prematch activities, the group's body
weight was still 2.2% lower than the pretest values, and peak
work capacity was still decreased. Even though wrestlers have
the opportunity to rehydrate after weigh in, performance is still
affected.3' Dehydration has also been shown to affect the
thermal regulation of the body. Body weight loss of 5%
significantly increases the risk of a wrestler's experiencing
some type of heat-related illness.3 As an athlete continues to
exercise in a dehydrated state, the body is unable to fully cool
itself, which may lead to decreased renal blood flow and
eventually kidney failure, decreased cardiac output, and even
death.3
The medical records for our patient revealed a diagnosis of
syncope and atypical chest pains due to a combination of an
OTC stimulant (Ripped Fuel), dehydration, and vigorous
exercise. Burke et al34 defined syncope as a brief and sudden
loss of consciousness and muscle tone secondary to some
contributory factor. Contributory factors to syncope can in-
clude hyperventilation, dehydration, hypoglycemia, electrolyte
imbalances, increased temperature and humidity, drug use, and
cardiac conditions.35 A number of factors could have contrib-
uted to the syncope experienced by this athlete. As stated
previously, ephedrine use can cause syncope and unrespon-
siveness.19 Heat illness and dehydration cause syncope.20'35'36
The athlete in this report exhibited increased levels of creati-
nine in the urinalysis due to dehydration. The dehydration
levels involved with "cutting weight" possibly contribute to
syncope. Cardiac conditions can contribute to syncope.35
While no cardiac conditions like hypertrophic cardiomyopathy,
myocardial infarction, or myocardial necrosis were diagnosed,
the athlete suffered from tachycardia and atypical chest pains
for approximately 2 hours. Thus, the cardiac abnormalities may
have contributed to the syncope. The athlete exhibited hyper-
ventilation during the episode and 2 hours thereafter. Since
hyperventilation can cause syncope, it may have been a
contributing factor.35 Because it is impossible to truly deter-
mine the exact cause of the syncopic episode and chest pains
experienced by the athlete, we can only speculate as to the
cause. We have noted several cases similar to this, in which
ephedrine products were believed to have contributed to injury
or illness.'7"1924
CONCLUSION
This case study is unique in that it involves a collegiate
wrestler experiencing syncope and atypical chest pains while
attempting to lose weight. Whether the syncope and atypical
chest pains resulted from the combination of exercise, dehy-
dration, and Ripped Fuel or from a single cause, athletic
trainers and coaches must understand not only the dangers of
"cutting weight" but also the dangers of using unregulated
stimulants like Ripped Fuel to aid in weight loss. The recent
deaths of 3 collegiate wrestlers over a 2-month period while
attempting to lose a substantial amount of weight have in-
creased awareness of the dangers involved with "cutting
weight." Using a stimulant like Ripped Fuel may compound
the risk of excessive weight loss.
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